Erik Carl-Max H.

Erik Carl-Max H. began their work experience at Pfizer Global Research & Development in 2000 as a Scientist. Erik Carl-Max worked in this role until May 2015. In May 2015, Erik joined Mirati Therapeutics as a Senior Clinical Research Manager, a position they held until December 2021. From January 2022, Erik took on the role of Associate Director of Clinical Operations at Mirati Therapeutics.

Erik Carl-Max H. obtained a Master's degree in Clinical Research from UC San Diego in 2010. Prior to that, they earned a Bachelor's degree in Biology, General from Portland State University, completing it between 1996 and 1999. Erik Carl-Max also participated in a semester abroad program at the University of Newcastle, focusing on General Science, in 1996. In 1995, Erik undertook another semester abroad program at Central Queensland University, Australia, with a concentration in General Science.